Full Text View
Tabular View
No Study Results Posted
Related Studies
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
This study has been completed.
Study NCT00035620   Information provided by Amgen

First Received on May 3, 2002.   Last Updated on February 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma
Neutropenia
More general conditions related to this trial
Agranulocytosis
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Interventions listed in this trial
pegfilgrastim
filgrastim
Additional drug interventions recognized in this trial
Lenograstim
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services